Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Mar 24, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Apr 02, 2025
Read More Apparatus New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Mar 12, 2025
